TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Chiesi; Abbott Vascular; Abiomed; Pfizer</li></ul>